Companies: 10,795·Total market cap: $144.5T
Cresco Labs Inc.

Cresco Labs Inc.

CL.CNCNQHealthcare● Active
$1.32
+$0.08(+6.45%)
Market Cap$467577788
P/E Ratio
52W High$3.12
52W Low$0.6
Overview

Cresco Labs Inc.(CL.CN)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

cl.cn · 股价预测 · 6 位分析师(近3月)· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 6 位华尔街分析师

SellBuy

Buy

6 位分析师

共识

评级分布

Strong Buy
0
Buy
3
Hold
3
Sell
0
Strong Sell
0
合计: 6 · 买入占比: 50.0%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $1.28

Cresco Labs Inc.(CL.CN)的分析师共识为 Buy,基于过去 3 个月内 6 位华尔街分析师的评级。CL.CN 的 12 个月平均目标价为 $0.00,相对当前价 $1.28 代表 +0.0% 的潜在上行空间。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$1.280.04%

1-day model range: $1.27–$1.29. Peak: $1.29 (-0.04%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

43%21%36%
6Buy
3Neutral
5Sell
RSI (14)60.6Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · CL.CN · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$1.25BUY
MA 10$1.26BUY
MA 20$1.25BUY
MA 50$1.32SELL
MA 100$1.37SELL
MA 200$0.00NEUTRAL
Current $CL.CN · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$1.26BUY
EMA 10$1.26BUY
EMA 20$1.28BUY
EMA 50$1.32SELL
EMA 100$1.41SELL
EMA 200$0.00NEUTRAL
Current $CL.CN · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Needham2024-05-16
Maintains
HoldHold
Wedbush2024-05-16
Maintains
OutperformOutperform
Roth MKM2024-03-14
Maintains
NeutralNeutral
Wedbush2023-03-20
Maintains
OutperformOutperform
Cantor Fitzgerald2023-02-24
Maintains
OverweightOverweight
Cantor Fitzgerald2022-12-30
Maintains
OverweightOverweight
Cowen & Co.2022-12-20
Downgrade ↓
OutperformMarket Perform
Piper Sandler2022-08-18
Maintains
OverweightOverweight
Cantor Fitzgerald2022-08-18
Maintains
OverweightOverweight
Piper Sandler2022-03-24
Maintains
OverweightOverweight

Wall Street analysts have recently issued updated ratings on Cresco Labs Inc. (CL.CN) stock. Of the recent 21 rating actions, 0 were upgrades and 1 were downgrades. 6 analysts currently cover CL.CN.

分析师推荐趋势

Buy ratings211
Hold ratings01↑ +1
Sell ratings00

CL.CN analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$652M

↓ 3.3% YoY

Revenue Next Year

$675M

↑ 3.6% YoY

EPS This Year

$-0.08

EPS Next Year

$-0.01

↓ 92.2% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CL.CN EPS of $-0.08 for the current fiscal year, based on estimates from 1 analysts. The CL.CN revenue forecast is $652M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

CL.CN 股价预测由两类独立数据源支撑:来自 6 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。CL.CN 的共识目标价为 $0.00(+0.0% 上行空间),分析师共识为 Buy。

CL.CN 的短期预测(明日)为 $1.28(-0.04%)。

Cresco Labs Inc. 在 CNQ 上市,代码 CL.CN。CL.CN 在 2027 年的整体展望偏积极,在覆盖分析师中约 50% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

CL.CN 预测 · 8 个问题

根据 6 位华尔街分析师,CL.CN 的 12 个月平均目标价为 $0.00,最高 $0.00、最低 $0.00。若有图表,中位目标价可在上方查看。相对当前价 $1.28,隐含约 +0.0% 的上行空间。

CL.CN 目标价CL.CN 分析师目标价CL.CN 12个月目标价目标价 CL.CN

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.